Connor Wells J, Mullin MM, Ho C, Melosky B, et al. Outcomes of patients with advanced epithelial growth factor receptor mutant lung cancer treated with first-line osimertinib who would not have met the eligibility criteria for the FLAURA clinical trial. Lung Cancer 2024;190:107529.
PMID: 38452600